R-Spondin-1 Human Recombinant
R-Spondin-1 Human Recombinant produced in CHO cells is a glycosylated monomer chain containing 243 amino acids and having a total molecular mass of 25.6kDa.
RSPO1 is purified by proprietary chromatographic techniques.
CHO cells.
R-Spondin-3 Human Recombinant
Recombinant Human R-Spondin-3 produced in HEK293 cells is a polypeptide chain starting at amino acid Gln at position 22 to amino acid Val at position 201, fused to an FC, 6 x His-tag at C-terminus, containing a total of 498 amino acids and having a Mw of 47.9 kDa. The protein migrates at 61kDa on SDS-PAGE.
RSPO3 is a truncated protein that lacks amino acid Gln at position 201 to amino acid H at position 272 and purified by proprietary chromatographic techniques.
Recombinant Human Spondin-1
SPON1 Human Recombinant produced in HEK293 cells is a single, glycosylated, polypeptide chain (29-807 a.a) containing a total of 785 amino acids, having a molecular mass of 88.9 kDa.
SPON1 is fused to a 6 amino acid His-tag at C-terminus,and is purified by proprietary chromatographic techniques.
Key Biological Properties: RSPOs are approximately 35 kDa proteins characterized by two amino-terminal furin-like repeats and a thrombospondin domain . They are secreted agonists of the canonical Wnt/β-catenin signaling pathway .
Expression Patterns and Tissue Distribution: RSPOs are expressed in various tissues, including the neural tube during development, bone, skeletal muscle, pancreatic β-cells, and intestinal stem cells . They play crucial roles in cell proliferation, differentiation, and death .
Primary Biological Functions: RSPOs enhance responses to low-dose Wnt proteins and are involved in cell proliferation, differentiation, and tissue regeneration . They are also crucial in the development of various organs and the maintenance of adult stem cells .
Role in Immune Responses and Pathogen Recognition: RSPOs have been shown to enhance antitumor immunity by promoting the infiltration and function of cytotoxic effector cells, such as NK cells and T cells, within the tumor microenvironment .
Mechanisms with Other Molecules and Cells: RSPOs interact with the Frizzled/LRP6 receptor complex to stimulate the Wnt/β-catenin signaling pathway . They act upon cognate receptors LGR4/5/6, which are typically expressed by stem cells and progenitor cells .
Binding Partners and Downstream Signaling Cascades: RSPOs bind to LGR4/5/6 receptors, leading to the activation of the Wnt/β-catenin signaling pathway . This interaction results in the potentiation of Wnt signaling, which is crucial for stem cell maintenance and differentiation .
Regulatory Mechanisms Controlling Expression and Activity: RSPOs are regulated at both the transcriptional and post-translational levels. Transcriptional regulation involves the expression of RSPO genes in response to various developmental cues . Post-translational modifications, such as glycosylation, play a role in the stability and activity of RSPO proteins .
Biomedical Research: RSPOs are used in regenerative medicine due to their mitogenic activity in stem cells . They have potential therapeutic applications in treating conditions such as intestinal mucositis, inflammatory bowel diseases, and diabetes mellitus .
Diagnostic Tools and Therapeutic Strategies: RSPOs are being explored as therapeutic targets in cancer treatment due to their role in enhancing antitumor immunity and potentiating Wnt signaling . They are also used in tissue engineering and cell therapy .
Role Throughout the Life Cycle: RSPOs play essential roles in various stages of life, from embryonic development to aging. During development, they regulate organ formation and cell fate determination . In adults, they maintain tissue homeostasis and promote tissue regeneration . Dysregulation of RSPOs has been linked to various diseases, including cancer .